Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)

Overview of attention for article published in Trials, April 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 49 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,408 followers.

RT @hsru_aberdeen: The protocol for our BICS trial has been published in @BioMedCentral Trials. BICS is assessing effectiveness of the beta…

21 Apr 2022

Reply Repost Favourite

The protocol for our BICS trial has been published in @BioMedCentral Trials. BICS is assessing effectiveness of the beta-blocker bisoprolol in preventing exacerbations of #COPD https://t.co/k9AkEyiBMA

21 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.